Open AccessTreatment of Diabetic Macular Edema with Aflibercept and Micropulse Laser (DAM Study)
Author(s) -
Keyvan Koushan,
Arshia Eshtiaghi,
Pauline Fung,
Alan R. Berger,
David R. Chow
Publication year - 2022
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s360869
Subject(s) - medicine , aflibercept , ophthalmology , diabetic macular edema , visual acuity , pro re nata , randomized controlled trial , macular edema , laser coagulation , diabetic retinopathy , ranibizumab , surgery , bevacizumab , diabetes mellitus , chemotherapy , endocrinology
To investigate the safety and efficacy of micropulse (MP) macular laser in combination with intravitreal aflibercept for the treatment of center-involved diabetic macular edema (CI-DME).